Live flavivirus vaccines: reasons for caution.

PubWeight™: 3.36‹?› | Rank: Top 1%

🔗 View Article (PMID 15207960)

Published in Lancet on June 19, 2004

Authors

Stephen J Seligman1, Ernest A Gould

Author Affiliations

1: Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA. stephen_seligman@nymc.edu

Articles citing this

A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med (2006) 1.55

Substitution of wild-type yellow fever Asibi sequences for 17D vaccine sequences in ChimeriVax-dengue 4 does not enhance infection of Aedes aegypti mosquitoes. J Infect Dis (2008) 1.23

Rewiring the severe acute respiratory syndrome coronavirus (SARS-CoV) transcription circuit: engineering a recombination-resistant genome. Proc Natl Acad Sci U S A (2006) 1.22

Multiple recombinant dengue type 1 viruses in an isolate from a dengue patient. J Gen Virol (2007) 1.16

A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus. J Virol (2008) 1.13

Size heterogeneity in the 3' noncoding region of South American isolates of yellow fever virus. J Virol (2005) 1.06

A trans-complementing recombination trap demonstrates a low propensity of flaviviruses for intermolecular recombination. J Virol (2010) 1.05

Identification and manipulation of the molecular determinants influencing poliovirus recombination. PLoS Pathog (2013) 0.98

Recombination of Globally Circulating Varicella-Zoster Virus. J Virol (2015) 0.94

Identification of mutated cyclization sequences that permit efficient replication of West Nile virus genomes: use in safer propagation of a novel vaccine candidate. J Virol (2008) 0.92

Arguments for live flavivirus vaccines. Lancet (2004) 0.91

Flavitrack: an annotated database of flavivirus sequences. Bioinformatics (2007) 0.87

Issues related to recent dengue vaccine development. Trop Med Health (2011) 0.86

Arguments for live flavivirus vaccines. Lancet (2004) 0.86

Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment. Vaccine (2014) 0.84

Dual miRNA targeting restricts host range and attenuates neurovirulence of flaviviruses. PLoS Pathog (2015) 0.84

Multiple recombinants in two dengue virus, serotype-2 isolates from patients from Oaxaca, Mexico. BMC Microbiol (2009) 0.83

Concurrent micro-RNA mediated silencing of tick-borne flavivirus replication in tick vector and in the brain of vertebrate host. Sci Rep (2016) 0.81

Bioinformatics in new generation flavivirus vaccines. J Biomed Biotechnol (2010) 0.81

Arguments for live flavivirus vaccines. Lancet (2004) 0.80

West Nile virus (WNV) genome RNAs with up to three adjacent mutations that disrupt long distance 5'-3' cyclization sequence basepairs are viable. Virology (2011) 0.80

Stability of yellow fever virus under recombinatory pressure as compared with chikungunya virus. PLoS One (2011) 0.79

Synergistic Internal Ribosome Entry Site/MicroRNA-Based Approach for Flavivirus Attenuation and Live Vaccine Development. MBio (2017) 0.75

Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains. Vaccine (2016) 0.75

Product review on the JE vaccine IXIARO. Hum Vaccin Immunother (2015) 0.75

Articles by these authors

Chikungunya virus adapts to tiger mosquito via evolutionary convergence: a sign of things to come? Virol J (2008) 3.39

Phylogenetic relationships and differential selection pressures among genotypes of dengue-2 virus. Virology (2002) 2.75

Phylogenetic analysis reveals a low rate of homologous recombination in negative-sense RNA viruses. J Gen Virol (2003) 2.43

Serological evidence of West Nile virus, Usutu virus and Sindbis virus infection of birds in the UK. J Gen Virol (2003) 2.17

Genetic characterization of tick-borne flaviviruses: new insights into evolution, pathogenetic determinants and taxonomy. Virology (2006) 2.01

Complete genome analysis and molecular characterization of Usutu virus that emerged in Austria in 2001: comparison with the South African strain SAAR-1776 and other flaviviruses. Virology (2004) 1.98

Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Res (2009) 1.87

Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res (2013) 1.85

Tick cell lines: tools for tick and tick-borne disease research. Trends Parasitol (2007) 1.48

Potential risks associated with the proposed widespread use of Tamiflu. Environ Health Perspect (2007) 1.39

Tick-borne flaviviruses. Adv Virus Res (2003) 1.36

Molecular evolution of the insect-specific flaviviruses. J Gen Virol (2011) 1.34

Neutralizing antibodies after infection with dengue 1 virus. Emerg Infect Dis (2007) 1.33

The crystal structures of Chikungunya and Venezuelan equine encephalitis virus nsP3 macro domains define a conserved adenosine binding pocket. J Virol (2009) 1.32

A simple method for molecular detection of Swine-origin and human-origin influenza a virus. Vector Borne Zoonotic Dis (2010) 1.27

Genomics and evolution of Aedes-borne flaviviruses. J Gen Virol (2009) 1.26

Nonviremic transmission of West Nile virus. Proc Natl Acad Sci U S A (2005) 1.22

Mortality following peripheral infection with tick-borne encephalitis virus results from a combination of central nervous system pathology, systemic inflammatory and stress responses. Virology (2009) 1.18

Detection of seroconversion to West Nile virus, Usutu virus and Sindbis virus in UK sentinel chickens. Virol J (2006) 1.16

Taxonomy of the virus family Flaviviridae. Adv Virus Res (2003) 1.14

Sandfly-borne phleboviruses of Eurasia and Africa: epidemiology, genetic diversity, geographic range, control measures. Antiviral Res (2013) 1.13

Likely correlation between sources of information and acceptability of A/H1N1 swine-origin influenza virus vaccine in Marseille, France. PLoS One (2010) 1.12

CD8+ T-cells mediate immunopathology in tick-borne encephalitis. Virology (2008) 1.12

Novel virus discovery and genome reconstruction from field RNA samples reveals highly divergent viruses in dipteran hosts. PLoS One (2013) 1.10

Universal primers that amplify RNA from all three flavivirus subgroups. Virol J (2008) 1.09

Mutations in the NS2B and NS3 genes affect mouse neuroinvasiveness of a Western European field strain of tick-borne encephalitis virus. Virology (2008) 1.06

Genomic and antigenic characterization of the newly emerging Chinese duck egg-drop syndrome flavivirus: genomic comparison with Tembusu and Sitiawan viruses. J Gen Virol (2012) 1.06

The potential for West Nile virus to establish outside of its natural range: a consideration of potential mosquito vectors in the United Kingdom. Trans R Soc Trop Med Hyg (2004) 1.05

Understanding the dengue viruses and progress towards their control. Biomed Res Int (2013) 1.02

Virus evolution during a severe dengue epidemic in Cuba, 1997. Virology (2005) 0.93

Dengue virus type 3, Cuba, 2000-2002. Emerg Infect Dis (2005) 0.92

Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies. Viruses (2013) 0.91

Random codon re-encoding induces stable reduction of replicative fitness of Chikungunya virus in primate and mosquito cells. PLoS Pathog (2013) 0.90

The importance of being outer: consequences of the distinction between the outer and inner surfaces of flavivirus glycoprotein E. Trends Microbiol (2003) 0.89

Comparative genomic and phylogenetic analysis of the first Usutu virus isolate from a human patient presenting with neurological symptoms. PLoS One (2013) 0.87

With reference to Mexican flu. Influenza Other Respir Viruses (2009) 0.86

Early detection of tick-borne encephalitis virus spatial distribution and activity in the province of Trento, northern Italy. Geospat Health (2007) 0.84

Novel insect-specific flavivirus isolated from northern Europe. Virology (2012) 0.84

Amino acid changes responsible for attenuation of virus neurovirulence in an infectious cDNA clone of the Oshima strain of tick-borne encephalitis virus. J Gen Virol (2004) 0.84

Cell lines from the soft tick Ornithodoros moubata. Exp Appl Acarol (2009) 0.82

Non-hemagglutinating flaviviruses: molecular mechanisms for the emergence of new strains via adaptation to European ticks. PLoS One (2009) 0.82

Safety concerns with regard to live attenuated flavivirus vaccines. J Infect Dis (2008) 0.79

Alkhurma hemorrhagic fever in travelers returning from Egypt, 2010. Emerg Infect Dis (2011) 0.78

West Nile virus: don't underestimate its persistence. J Infect Dis (2010) 0.77

Comparative analysis of rodent tissue preservation methods and nucleic acid extraction techniques for virus screening purposes. J Virol Methods (2013) 0.77

Expecting the unexpected: nucleic acid-based diagnosis and discovery of emerging viruses. Expert Rev Mol Diagn (2011) 0.75

A rapid and simple procedure for direct cloning of PCR products into baculoviruses. Methods Mol Biol (2002) 0.75

Lineage-Specific Real-Time RT-PCR for Yellow Fever Virus Outbreak Surveillance, Brazil. Emerg Infect Dis (2017) 0.75